Company / Free Cash Flow
Rani Therapeutics Holdings, Inc. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$35.8M
FY2025
5-year range
-$52.5M / -$16.2M
FY2021-FY2025
Trend
+31.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$36M.
Based on SEC 10-K filings.
-$36M in FY2025.
Declined from -$33M to -$36M over the past 3 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 31.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$35.8M | +31.8% |
| FY2024 | -$52.5M | -60.2% |
| FY2022 | -$32.8M | -102.7% |
| FY2021 | -$16.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026